$CMS

CMS Maintained by Jefferies -- Price Target Lowered to $74.00

Jefferies maintained a 'Hold' rating for CMS Energy (CMS) but lowered its price target from $78 to $74. CMS is currently trading at $66.34, which is 12.1% below its GF Value™ of $75.51, according to GuruFocus. The company has a GF Score™ of 69/100, indicating moderate performance. Six gurus hold positions in CMS, with mixed activity in recent quarters.

Original reporting
Published Sep 15, 2026, 4:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 15, 2026, 9:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CMS
Bearish
medium confidence
Mentioned
$CMS
Relevance
7/10
AlphAI data visualization · based on gurufocus.com
Decision brief

The 30-second read

$CMSBearishMed
01

Why it matters

Analyst target reduction may trigger short‑term price adjustments but does not change the fundamental outlook.

02

Market read

Analyst price‑target update offers a modest trading signal for CMS Energy.

03

What to watch

Potential upside from renewable projects in NorthStar Clean Energy not fully priced in.

Relevance 7/10Novelty 6/10Timing: today

Background

CMS Energy provides regulated gas and electric service in Michigan and operates renewable generation.

Company-level read

Ticker impact

$CMSBearishMedium confidence
Context

Jefferies lowered its price target for CMS Energy from $78 to $74, indicating a fresh analyst view.

Expected impact

Potential 2‑3% pullback in the near term as investors digest the lower target.

Evidence & confidence

Analyst target revisions are a direct catalyst; the magnitude is modest and the rating remains Hold.

Market effects

Utility sector may see slight pressure as analysts reassess earnings outlooks.

Midwest utility investors could adjust exposure.

Limited; primarily affects US utility investors.

Counterpoint

Some investors may view the Hold rating and modest target cut as a buying opportunity if the stock is undervalued.

Key entities

  • Jefferies

    Maintains Hold rating on CMS Energy.

Related articles

$CMSLow

CMS Looks 11.1% Undervalued on GF Value™ Despite Operational Set

CMS Energy (NYSE: CMS) faces operational uncertainty after a court ruling invalidated an extension for its J.H. Campbell coal plant. The company's GF Value™ suggests it is 11.1% undervalued, but its financial health is weak, with a GF Score™ of 69. Insiders have sold more shares than they bought, while guru ownership remains stable. CMS's P/S ratio is 2.34x, slightly below its historical median.

$CMSMed

Cms energy stock hits 52-week low at 67.19 USD

CMS Energy's stock hit a 52-week low of $67.19, with a P/E ratio of 20.25 and a 3.37% dividend yield. Q2 2026 earnings of $0.37 per share missed expectations, but the company reaffirmed its full-year outlook. BMO Capital lowered its price target to $77, maintaining an Outperform rating.

$CMSLow

Federal appeals court blocks Trump administration bid to keep Michigan coal plant open

A federal appeals court ruled that the DOE exceeded its authority by forcing a Michigan coal plant to stay open beyond its planned 2025 closure. The decision impacts the Trump administration's efforts to keep aging coal plants operational. The plant's continued operation cost its owner, Consumers Energy, $295 million from May 2025 to June 2026, according to the Michigan attorney general's office.

$CMSMed

CMS begins clinical rollout of Silevimig, first bispecific antibody for rabies passive immunisation

China Medical System Holdings (CMS) has begun the clinical rollout of Silevimig, the world's first bispecific antibody for rabies passive immunisation. Initial prescriptions were issued at multiple hospitals in China. Silevimig is a Class 1 innovative drug with a smaller dose and lower injection volume compared to human rabies immune globulin (HRIG). It was approved in China in June 2026 and is manufactured using recombinant technology, eliminating the risk of blood-borne infections. CMS aims to

$CMSMed

Cms Energy stock hits 52-week low at 67.8 USD

CMS Energy (CMS) stock hit a 52-week low of $67.81, down 4.69% over the past year. The company reported Q2 2026 adjusted earnings of $0.37 per share on revenue of $1.83 billion, missing estimates. CMS has raised its dividend for 19 consecutive years, offering a current yield of 3.34%. Bank of America noted that most utilities companies surpassed earnings estimates, except for two, including CMS.